HPV vaccines discovered to be secure and well-tolerated in males

Human papillomavirus (HPV) is one of the most common sexually transmitted infections and cases of various cancers in both women and men. There are currently three vaccines available and their efficacy and safety in women, but not men, have been thoroughly studied. A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population and that the side effects that can occur after immunization are similar in both sexes.

The analysis included all post-immunization adverse event reports that were in the U.S. Vaccine Adverse Event Reporting System from January 1, 2006 to September 30, 2018.

“To the best of our knowledge, this is one of the first studies to evaluate the safety profile of HPV vaccines in men,” the authors wrote.

Source:

Journal reference:

Bonaldo, G. et al. (2020) Vaccination Against Human Papillomavirus In Men: A Pharmacovigilance Study of the Vaccine Adverse Event Reporting System. British Journal of Clinical Pharmacology. doi.org/10.1111/bcp.14584.

Comments are closed.